Red Light Therapy for Neuropathy: Evidence & Protocols
TL;DR
- Red light therapy has documented effects on nerve regeneration, pain reduction, inflammation, and circulation that are directly relevant to peripheral neuropathy. The evidence base is promising, particularly for diabetic peripheral neuropathy and chemotherapy-induced neuropathy.
- Near-infrared wavelengths (810nm to 940nm) are more relevant than surface red light for neuropathy treatment because peripheral nerves sit deeper in tissue than skin-level targets. Deeper penetrating wavelengths reach the nerve tissue more effectively.
- A key study published in the Journal of Orthopaedic Science (2010) demonstrated that red light LED irradiation at 660nm promoted nerve regeneration and improved antioxidation levels in nerve chamber fluid, providing direct evidence for the nerve repair mechanism.
- Typical protocols use 10 to 30 minute sessions, three to four times per week, with most people noticing meaningful symptom changes at four to six weeks of consistent use. Neuropathy is a condition that responds to cumulative treatment rather than single sessions.
- Neuropathy should always be managed in conjunction with a healthcare provider. Red light therapy is a complementary tool for symptom management and should not replace treatment of the underlying cause.
Peripheral neuropathy affects an estimated 2.4 million Australians, with symptoms ranging from burning pain, numbness, and tingling to muscle weakness and loss of coordination. The condition has many causes, from diabetes and chemotherapy to autoimmune disease and physical injury, and conventional management is often limited to symptom control through medication rather than addressing the underlying nerve damage.
Red light therapy is gaining significant attention as a non-drug option for neuropathy management, with a growing body of research documenting effects on nerve regeneration, inflammation, and circulation that address the core pathophysiology of the condition. This article works through the evidence, explains the relevant mechanisms, provides cause-specific guidance, and outlines practical protocols for at-home use.
What Is Peripheral Neuropathy?
Peripheral neuropathy is damage to the nerves outside the brain and spinal cord. The peripheral nervous system carries signals between the central nervous system and the rest of the body, including sensory signals from skin and muscles and motor signals to limbs and organs. When these nerves are damaged, signal transmission is disrupted, producing the characteristic symptoms of neuropathy.
The most commonly affected areas are the feet and hands, where the longest peripheral nerve fibres are most vulnerable to damage. Symptoms typically include:
- Burning, stabbing, or electric pain, often worse at night
- Numbness and reduced sensation in the feet, legs, and hands
- Tingling and pins and needles
- Sensitivity to touch, where even light contact is painful
- Muscle weakness and reduced coordination
- Balance and walking difficulties in more advanced cases
Common causes of peripheral neuropathy
Diabetes is the leading cause of peripheral neuropathy in Australia, with diabetic peripheral neuropathy affecting up to 50% of people with diabetes over time. Sustained elevated blood glucose damages the walls of small blood vessels supplying peripheral nerves, leading to progressive nerve fibre loss and the characteristic stocking-and-glove pattern of symptoms affecting feet and hands first.
Chemotherapy-induced peripheral neuropathy (CIPN) affects a significant proportion of cancer patients receiving neurotoxic chemotherapy agents including taxanes, platinum compounds, and vinca alkaloids. It is one of the most common reasons for dose reduction or discontinuation of chemotherapy and has no well-established standard of care, making complementary interventions including photobiomodulation an active area of research.
Other causes include autoimmune conditions including lupus and rheumatoid arthritis, infections including shingles, Lyme disease, and HIV, physical injury or compression, alcohol-related nerve damage, and hereditary conditions including Charcot-Marie-Tooth disease.
How Red Light Therapy Works for Neuropathy
Nerve regeneration
The most direct evidence for red light therapy's relevance to neuropathy comes from research on nerve regeneration. A 2010 study by Ishiguro et al. published in the Journal of Orthopaedic Science transected sciatic nerves in rat models and irradiated the nerve regeneration chamber with red light LEDs at 660nm for one hour daily. At three weeks post-surgery, the LED group showed significantly greater nerve regeneration histologically, and antioxidation levels in the nerve chamber fluid were maintained significantly higher in the treated group compared to controls. The researchers concluded that LED irradiation improved nerve regeneration by supporting mitochondrial oxidative metabolism and preserving antioxidation in the nerve microenvironment.
Near-infrared light has also been shown to stimulate Schwann cells, the specialised cells that form the myelin sheath insulating peripheral nerve fibres. A 2012 review in the Journal of Photochemistry and Photobiology documented that photobiomodulation promotes Schwann cell proliferation and nerve conduit formation, supporting the biological plausibility of red light therapy for demyelinating neuropathies where myelin sheath damage is a key pathological feature.
Pain reduction and inflammation
Neuropathic pain involves both peripheral sensitisation at the nerve ending level and central sensitisation in the spinal cord and brain. Red light therapy addresses the peripheral component through multiple mechanisms. A 2019 review of photobiomodulation for pain management documented that near-infrared light reduces the production of pro-inflammatory cytokines including TNF-alpha, IL-1beta, and IL-6 at the tissue level, decreasing the inflammatory signal that drives peripheral sensitisation. It also reduces reactive oxygen species that contribute to oxidative nerve damage, addressing one of the primary drivers of progressive neuropathy.
Beta-endorphin release and modulation of sodium channel activity have also been proposed as mechanisms through which red light therapy produces analgesic effects in neuropathic pain, providing multiple complementary pathways for pain reduction beyond the anti-inflammatory effect alone.
Improved circulation and microvascular health
In diabetic peripheral neuropathy specifically, damage to the small blood vessels supplying peripheral nerves is a primary driver of nerve fibre loss. Red light therapy's effects on nitric oxide production and vascular endothelial function are directly relevant here. A 2017 study in the Journal of Diabetes Research found that near-infrared light improved microvascular blood flow and reduced markers of endothelial dysfunction in diabetic subjects, supporting the vascular mechanism through which photobiomodulation may slow or partially reverse diabetic neuropathy progression.
Improved circulation to peripheral nerve tissue delivers more oxygen and nutrients to damaged nerve fibres, creating a more favourable microenvironment for repair and regeneration. This is the mechanism most directly relevant to the foot and lower limb symptoms that are most common in peripheral neuropathy.
Evidence by Neuropathy Type
Diabetic peripheral neuropathy
Diabetic peripheral neuropathy is the most studied application of red light therapy for neuropathy, with multiple randomised controlled trials documenting symptom improvements. A 2015 randomised controlled trial published in Photomedicine and Laser Surgery found that patients with diabetic peripheral neuropathy receiving near-infrared light treatment showed significant improvements in vibration perception threshold, pain scores, and nerve conduction velocity compared to sham treatment over a 10-week protocol. Vibration perception and nerve conduction improvements indicate actual nerve function recovery rather than just symptom masking.
For people with diabetes using red light therapy for neuropathy, monitoring blood glucose alongside any complementary therapy is important as some research has also documented effects of near-infrared light on insulin sensitivity and glucose metabolism that may affect diabetes management.
Chemotherapy-induced peripheral neuropathy
CIPN is an area of growing research for photobiomodulation. A 2020 pilot study in Supportive Care in Cancer found that photobiomodulation applied to the hands and feet of patients undergoing neurotoxic chemotherapy reduced CIPN severity scores and improved quality of life measures compared to a control group. Importantly, no interference with chemotherapy efficacy was observed, addressing one of the primary clinical concerns about using light-based interventions alongside cancer treatment.
For people undergoing active chemotherapy, discussing any complementary therapy including red light therapy with the treating oncologist before starting is essential. The evidence is early-stage but promising, and clinical trials are ongoing.
Post-surgical and trauma-induced neuropathy
For neuropathy following nerve compression, surgical injury, or physical trauma, red light therapy's nerve regeneration mechanisms are most directly applicable. The Ishiguro 2010 study used a nerve transection model, making its findings specifically relevant to post-traumatic nerve repair. A 2018 review of photobiomodulation for peripheral nerve repair found consistent evidence across multiple animal and human studies for accelerated nerve regeneration, improved motor and sensory recovery, and reduced scar tissue formation at injury sites with photobiomodulation treatment.
Wavelength Considerations for Neuropathy
Wavelength selection matters more for neuropathy than for many other applications because peripheral nerve tissue sits at varying depths depending on the body location being treated.
For foot and lower leg neuropathy, which is the most common presentation, peripheral nerve fibres at the treatment target sit several centimetres below the skin surface. Near-infrared wavelengths in the 810nm to 940nm range penetrate significantly deeper than visible red light at 630nm to 660nm, making NIR the more relevant wavelength range for reaching nerve tissue in the feet and lower limbs.
Extended near-infrared at 1060nm, delivered via VCSEL laser technology, provides the deepest tissue penetration of any commercially available therapeutic light wavelength. For the deepest peripheral nerve targets and for systemic inflammatory conditions contributing to neuropathy, this wavelength range has the most direct tissue access.
A combination device covering both red (660nm) and multiple NIR wavelengths (810nm, 830nm, 850nm, and above) provides the most comprehensive coverage for neuropathy treatment, addressing both superficial inflammatory processes and deeper nerve tissue targets in the same session.
Practical Protocol for Neuropathy
Session length and frequency
For neuropathy, sessions of 10 to 30 minutes per treatment area, three to four times per week, are the most consistent with clinical research protocols. Neuropathy is a condition that responds to cumulative treatment, meaning that the benefit builds with consistent use over weeks rather than being produced by single sessions.
Most people notice initial symptom changes at four to six weeks of consistent use. Meaningful nerve function improvements, where detectable, typically require longer treatment periods of eight to twelve weeks or more, reflecting the slow biological timescale of nerve repair.
Treatment area targeting
For foot and lower limb neuropathy, position the device to cover the soles of the feet, the top of the feet, the ankles, and the lower legs. Sessions of 10 to 15 minutes per position allow adequate dose delivery to each area.
For hand neuropathy, cover the palms, the dorsal surface of the hands, and the wrists. For people with both foot and hand neuropathy, alternating focus areas across sessions or extending session time to cover both in a single session are both practical approaches.
Positioning and distance
For near-infrared panels used for foot neuropathy, positioning the device 5 to 15cm from the treatment surface delivers irradiance in the 50 to 175 mW/cm² range depending on the device, which sits within the documented therapeutic window for nerve applications. Wearable contact devices applied directly to the skin deliver consistent dose regardless of positioning variability.
StreamShop Devices for Neuropathy
For neuropathy, the priority is delivering adequate near-infrared wavelengths to peripheral nerve tissue at appropriate depths. The following StreamShop devices are suited to neuropathy applications.
Red light therapy joint wrap
StreamShop's red light therapy joint wrap at $169.99 is the most practical option for localised neuropathy in the feet, ankles, and hands. Its flexible wearable design wraps directly around the affected area delivering 660nm and 850nm near-infrared at 120 mW/cm² in direct skin contact. The wireless 5000mAh rechargeable battery means no tethered power during sessions, making passive seated treatment easy. For neuropathy affecting balance and coordination, a device that can be applied without standing or repositioning is particularly practical. It fits the knee, ankle, wrist, and elbow, covering the most common peripheral neuropathy sites.
Red light therapy for legs
For people with lower leg and foot neuropathy affecting both limbs, StreamShop's red light therapy leg wrap delivers 650nm and 850nm near-infrared across 470 triple chip LEDs at up to 130 mW/cm² covering both legs from feet to knee in a single 15-minute session. Rather than treating one area at a time, the full leg wrap treats the entire lower limb bilaterally, which is the typical presentation of diabetic and chemotherapy-induced peripheral neuropathy. Four adjustable power levels allow gradual intensity increase as the treatment area responds.
SR72 panel ($399.99)
StreamShop's SR72 red light therapy panel delivers 660nm and 850nm wavelengths at 139 mW/cm² at 15cm. Positioned 5 to 15cm from the feet or lower legs during a seated session, it delivers both red and near-infrared wavelengths to the treatment area. The 850nm near-infrared component is the most relevant wavelength for peripheral nerve applications in this device. For people starting with red light therapy for neuropathy, the SR72 is a practical and cost-effective entry point.
SS300 Pro medical grade panel
StreamShop's SS300 Pro medical grade panel delivers 175.1 mW/cm² at 15cm across nine wavelengths including 810nm, 830nm, 850nm, and 1060nm near-infrared. For neuropathy patients wanting maximum wavelength coverage and the deepest tissue penetration, the SS300 Pro provides the most comprehensive near-infrared spectrum of the panel devices. The nine-wavelength combination covers multiple absorption peaks in nerve tissue, and the 1060nm wavelength provides the deepest penetration for lower limb applications where nerve targets are further from the surface.
Red light therapy laser bed
StreamShop's red light therapy laser bed uses 1064nm VCSEL laser technology for full-body treatment. For people with widespread neuropathy affecting multiple body areas, or for those whose neuropathy has a systemic inflammatory or vascular cause where whole-body treatment is relevant, the laser bed provides simultaneous full-body coverage at the deepest-penetrating wavelength available. This is the most comprehensive option for systemic neuropathy conditions.
Frequently Asked Questions
Does red light therapy help neuropathy?
Research supports red light therapy as a complementary approach for neuropathy management. Studies have documented improvements in pain scores, nerve conduction velocity, vibration perception, and circulation in people with peripheral neuropathy receiving photobiomodulation treatment. The evidence is strongest for diabetic peripheral neuropathy, with growing evidence for chemotherapy-induced neuropathy and post-traumatic nerve injury. It is best used alongside conventional medical management rather than as a standalone treatment.
Can red light therapy regenerate nerves?
Research on near-infrared light and nerve regeneration is promising. The Ishiguro 2010 study documented promoted nerve regeneration in a sciatic nerve transection model with daily LED irradiation, and multiple studies have documented stimulation of Schwann cells which are critical for myelin sheath repair. While complete regeneration of severely damaged nerves is unlikely from any intervention, photobiomodulation appears to support the biological conditions for nerve repair more effectively than no treatment.
How long does red light therapy take to work for neuropathy?
Most people notice initial symptom changes including reduced pain and improved sensation at four to six weeks of consistent use at three to four sessions per week. Measurable improvements in nerve function tests take longer, typically eight to twelve weeks or more. Neuropathy reflects structural nerve damage that repairs slowly, so patience and consistency are essential. Progress should be assessed over weeks and months rather than days.
What wavelength is best for neuropathy?
Near-infrared wavelengths in the 810nm to 940nm range are most relevant for peripheral nerve applications because they penetrate deeper than visible red light. For the deepest peripheral nerve targets in the lower limbs, 1060nm VCSEL laser technology provides the greatest tissue penetration. A combination device covering both near-infrared and extended NIR wavelengths provides the most comprehensive approach for neuropathy treatment.
Is red light therapy good for diabetic neuropathy?
Diabetic peripheral neuropathy is the most studied application of red light therapy for neuropathy. Multiple randomised controlled trials have documented improvements in pain scores, nerve conduction velocity, and vibration perception in people with diabetic neuropathy receiving near-infrared treatment. The vascular mechanism, where red light improves microvascular blood flow to peripheral nerve tissue, is particularly relevant to diabetic neuropathy where small vessel disease is a primary driver of nerve damage.
Can red light therapy help neuropathy in feet?
Foot neuropathy is the most common presentation of peripheral neuropathy and is well suited to red light therapy treatment. Wearable contact devices applied directly to the soles and tops of the feet deliver near-infrared light at consistent irradiance without requiring the person to maintain positioning. Panel devices used at close range with the feet positioned toward the device are also practical. The joint wrap is the most practical device for single foot or ankle neuropathy given its flexible wearable design and wireless operation. For bilateral lower leg neuropathy, the leg wrap covers both limbs simultaneously in a single session.
Is red light therapy safe for neuropathy?
Red light therapy is non-invasive, does not use ionising radiation, and has a strong safety profile in the general population. For neuropathy specifically, the primary safety consideration is reduced sensation in the affected area, which means people with severe sensory loss may not feel discomfort if a device generates significant heat. Using devices at recommended distances and checking skin temperature after sessions is appropriate. People with diabetes should also monitor blood glucose as some research documents metabolic effects of NIR light. Always consult your healthcare provider before starting.